TB-500 Tendon Recovery Diary: 90 Days of Notes From a Stubborn Patellar Tendon

TB-500 Tendon Recovery Diary: 90 Days of Notes From a Stubborn Patellar Tendon is best understood as a clinical decision topic, not a shortcut. The evidence, pharmacy source, dose plan, contraindications, and follow-up matter more than any single success story online.

I kept these notes in a spreadsheet. Every morning, before coffee, I’d poke the top of my kneecap, rate the pain, and type a number into a cell. Ninety days of that, plus two ultrasounds, plus a stack of physical therapy receipts I’d rather not think about. What follows is the spreadsheet lightly edited into prose, because I wanted to show the actual trajectory of a TB-500 protocol for chronic patellar tendinopathy, not the Instagram version.

Compliance note: TB-500 (a thymosin beta-4 fragment) is a research-stage peptide with no FDA approval for any human indication. It is accessed through compounding pathways, prepared by licensed 503A pharmacies based on a prescriber’s clinical judgment. The FDA placed thymosin beta-4 fragments on the 503A bulks list under review in 2023. Nothing here is medical advice.

The Knee That Wouldn’t Cooperate

Here is the practical read of 18 wasted months. I’m 40, recreational athlete, right knee. Ultrasound-confirmed patellar tendinopathy with significant thickening at the proximal insertion. I did the eccentric loading. I did the physical therapy, three times a week, with a therapist named David in Austin who genuinely tried everything in his toolkit. I did two PRP injections at $1,400 each. The whole regimen improved symptoms by maybe 40 percent and then just… stopped. Plateaued. Morning pain sat at a 5 out of 10. Stairs were a 6. Deep squats were a memory.

David actually said it first: “You might be a candidate for peptide therapy.” My sports medicine doctor agreed when I brought it up. He was straightforward about the evidence gap. The strongest data is animal studies. Human data is limited. But for patients who’ve genuinely failed conservative care and want to try something before a more invasive procedure, he uses TB-500 selectively. “I’m not promising you anything,” he said during the intake consult. “I’m offering you a well-documented experiment.”

That framing worked for me.

The Protocol, Laid Out Plain

• Dose: 5 mg subcutaneous, twice weekly
• Injection sites: alternating between abdomen and proximal thigh on the affected side
• Duration: 90 days, followed by a planned 60-day off period
• Concurrent treatment: same physical therapy load continued; no NSAIDs; no other peptides
• Baseline documentation: ultrasound of the patellar tendon, knee flexion ROM, single-leg squat test, pain scale

The rules were deliberate. My doctor wanted a clean evaluation. No stacking with BPC-157, no anti-inflammatory medications, no training volume changes that would confuse the signal. One variable at a time.

See also: The Role of Developers in Blockchain Growth

Weeks 1 and 2: A Whole Lot of Nothing

Almost nothing happened. Mild warmth at the injection site for about an hour after each shot. Knee pain? Unchanged. I sat at my desk on day 10 reading my spreadsheet, which was just a column of 5s, and thought, “Well, this is $720 worth of saline.”

The published animal data on thymosin beta-4 fragments shows a delayed response curve. Effects accumulate over weeks rather than producing any immediate relief. My doctor had warned me. I kept logging.

Weeks 3 and 4: The Numbers Shifted Before I Noticed

Day 18 is when the spreadsheet told me something my body hadn’t quite announced yet. Morning pain dropped from a 5 to a 3. I had to re-read the log to confirm it was real. Stair climbing improved from a 6 to a 4. Single-leg squat depth gained about 10 degrees of knee flexion before pain stopped me.

Sleep? Unchanged. Mood? Unchanged. No injection-site reactions beyond the brief warmth. No detectable changes in any other domain. The knee was quietly, boringly, getting a little bit better.

Weeks 5 Through 8: The Productive Window

This stretch was the heart of it. Morning pain dropped from a 3 to a 1 over roughly three weeks. Stair climbing essentially normalized. I started adding light loaded squats back into training, beginning with bodyweight and slowly progressing to a 95-pound bar by day 55.

By palpation, the patellar tendon felt less tender at the proximal insertion. I want to be careful here. I’m not claiming structural change based on pressing my thumb into my kneecap. Just reduced tenderness.

Around day 50 I made a mistake. Too much volume in one session, too much enthusiasm. Pain spiked back to a 4 for two days. But the recovery from that flare was noticeably faster than any similar flare during the previous 18 months. By day 52 I was back to a 1. That speed of recovery felt like the most convincing data point in the whole protocol.

Weeks 9 Through 12: Diminishing Returns, Real Imaging

Pain settled at a baseline of 0 to 1 most days. Stairs were fine. Single-leg squat gained another 5 degrees of flexion before any pain limit. I started reintroducing jumping and plyometric work in week 12, carefully.

The 90-day ultrasound was the moment that mattered. It showed reduced echogenicity at the proximal insertion compared to baseline. The radiologist’s note: “interval improvement in tendinopathy appearance.” That is not a clean structural reversal. But it’s a documented imaging change in the right direction, and it’s the kind of data point that separates a real protocol from a testimonial.

Side Effects: Boring, Thankfully

• Mild post-injection warmth in the first two weeks, then resolved
• One transient headache around day 20 (not clearly attributable to the peptide)
• Two episodes of mild fatigue lasting half a day, once in week 4 and once in week 9 (unclear attribution)
• No injection-site lumps, no edema, no joint pain in unaffected areas, no glucose changes on labs
• Blood pressure stable throughout. Resting heart rate stable.

The boring truth is that the side effect profile was essentially nonexistent for me. Your mileage, as with everything compounded, may vary.

What I Deliberately Avoided

No BPC-157 stack. The popular internet protocol combines TB-500 and BPC-157 for soft tissue work. My doctor vetoed it. One variable. I plan to try the combination in a future block once the off period is complete.

No NSAIDs. The literature on whether anti-inflammatory drugs blunt the connective tissue repair signal is mixed, but mixed is enough reason to stay clean during an experiment.

No aggressive training changes. I let the symptom relief lead the loading, not the reverse. This part mattered. I’ve watched people on peptide forums add TB-500, feel 60 percent better, then jump straight back into heavy training like they’re 25. Predictable results.

38 Days Off: Did the Gains Hold?

I’ve been off TB-500 for 38 days as I write this. The improvements have held. Morning pain stays at 0 to 1. Stairs are normal. I’ve continued physical therapy and progressive loading throughout the off period.

The ultrasound at day 30 of the off period showed continued slow improvement in tendon appearance compared to the end-of-protocol scan. My doctor’s interpretation: the peptide may have catalyzed a healing process that is now self-sustaining through the body’s own repair signaling. That’s a hypothesis, not a conclusion.

What It Cost

The 90-day course ran about $720 through this peptide source, a compounded telehealth pharmacy working with licensed 503A compounding pharmacies to fulfill my prescription. That includes the product itself and prescriber consults at intake, mid-protocol, and end-of-protocol. One more PRP injection in my area would have been $1,200 to $1,800. The math worked.

Where This Falls Apart Without Discipline

I would not run this protocol without a real prescriber and real imaging. The reason this result felt convincing, to me and to my doctor, was that we had baseline ultrasound, a structured protocol, and post-protocol imaging for comparison. Without that infrastructure, every peptide claim is just a vibe. And there’s no shortage of vibes in this space.

I’d also never recommend this as a first-line treatment. TB-500 is not a substitute for physical therapy and eccentric loading. It is, at best, an adjunct for people who have genuinely exhausted the standard toolkit and aren’t ready for surgery.

What Comes Next

A 90-day block of BPC-157 plus TB-500, starting in about three months, targeting the residual structural abnormality that still shows up at the proximal patellar insertion. Same documentation discipline. Same imaging at baseline and end.

If the abnormality keeps improving, I’ll cycle these protocols every 9 to 12 months as maintenance. If not, I’ll reassess whether peptide therapy belongs in my care plan at all.

I’ll update this page either way.

Compliance disclaimer: TB-500 is not FDA-approved. It is prescribed off-label and prepared by licensed 503A pharmacies for individual patients based on clinical judgment. This is one patient’s documented experience, not medical advice.

Frequently Asked Questions

How long before TB-500 showed any effect on my tendon pain? About 18 days. The first two weeks were essentially a flatline. Published animal data on thymosin beta-4 fragments supports a delayed response curve, which my prescriber warned me about upfront.

What dose of TB-500 did you use? 5 mg subcutaneous, twice weekly, for 90 days. This was prescribed based on my doctor’s clinical judgment and my body weight.

Did you stack TB-500 with BPC-157? Not during this protocol. My doctor wanted a single-variable evaluation. I plan to combine them in a future block.

What did the post-protocol ultrasound show? Reduced echogenicity at the proximal patellar insertion compared to baseline. The radiologist noted “interval improvement in tendinopathy appearance.” Not a complete structural reversal, but a measurable imaging change.

Did the improvements last after stopping TB-500? At 38 days off, yes. Pain stayed at 0 to 1, stair climbing remained normal, and a follow-up ultrasound showed continued slow improvement. I maintained physical therapy and progressive loading throughout the off period.

How much did the full 90-day protocol cost? Approximately $720, including the peptide and three prescriber consults. That compares to $1,200 to $1,800 for a single PRP injection in my area.

Is TB-500 FDA-approved? No. TB-500 is a research-stage peptide with no FDA approval for any human indication. It is accessed through compounding pathways and prepared by licensed 503A pharmacies based on a prescriber’s clinical judgment. The FDA placed thymosin beta-4 fragments on the 503A bulks list under review in 2023.